肠道准备不能降低子宫切除术后感染并发症
基于美国大型商业健康计划数据库2006–2017年224687例子宫切除术(良性186148例,恶性38539例),采用倾向评分加权分析发现,机械性肠道准备、口服抗生素或两者联合均未降低30天手术部位感染、吻合口漏或重大并发症发生率,良性或恶性子宫切除术后均可安全省略肠道准备。
要点
- 肠道准备不降低子宫切除术后30天手术部位感染、吻合口漏或重大并发症。
- 良性与恶性子宫切除术后,无论手术途径,肠道准备均无保护作用。
- 恶性开腹子宫切除术中,机械准备、口服抗生素或联合方案与无准备无差异。
核心结论
- 肠道准备不能预防良性或恶性子宫切除术后的手术部位感染或重大并发症,无论手术途径,均可安全省略。
研究设计与样本
- 基于OptumLabs美国大型商业健康计划数据库的回顾性队列研究,纳入2006年1月至2017年7月间224687例子宫切除术(良性186148例,恶性38539例)。
- 对良性和恶性组分别采用逆倾向评分加权平衡基线特征,主要结局采用多因素logistic回归分析。
主要发现
- 良性队列中位年龄45岁,恶性队列54岁;良性组腹腔镜/机器人27.2%、开腹32.6%、阴道40.2%,恶性组分别为28.8%、47.7%、23.5%。
- 良性组肠道切除0.4%,恶性组2.8%。
- 良性组无肠道准备93.8%、仅机械准备4.6%、仅口服抗生素1.1%、机械准备联合口服抗生素0.5%;恶性组分别为87.2%、9.6%、1.8%、1.4%。
- 肠道准备未降低良性或恶性子宫切除术后手术部位感染、吻合口漏或重大并发症发生率。
- 恶性开腹子宫切除术中,仅机械准备、仅口服抗生素或联合方案与无准备相比,感染并发症发生率无差异。
临床怎么用
- 良性或恶性子宫切除术(包括开腹、腹腔镜/机器人及阴道途径)前可安全省略肠道准备,不必为降低感染并发症而常规使用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Literature on the use of bowel preparation in gynecologic surgery is scarce and limited to minimally invasive gynecologic surgery. The decision on the use of bowel preparation before benign or malignant hysterectomies is mostly driven by extrapolating data from the colorectal literature. OBJECTIVE: Bowel preparation is a controversial element within enhanced recovery protocols, and literature investigating its efficacy in gynecologic surgery is scarce. Our aim was to determine if mechanical bowel preparation alone, oral antibiotics alone, or a combination are associated with decreased rates of surgical site infections or anastomotic leaks compared to no bowel preparation following benign or malignant hysterectomy. STUDY DESIGN: We identified women who underwent hysterectomy between January 2006 and July 2017 using OptumLabs, a large US commercial health plan database. Inverse propensity score weighting was used separately for benign and malignant groups to balance baseline characteristics. Primary outcomes of 30-day surgical site infection, anastomotic leaks, and major morbidity were assessed using multivariate logistic regression that adjusted for race, census region, household income, diabetes, and other unbalanced variables following propensity score weighting. RESULTS: A total of 224,687 hysterectomies (benign, 186,148; malignant, 38,539) were identified. Median age was 45 years for the benign and 54 years for the malignant cohort. Surgical approach was as follows: benign: laparoscopic/robotic, 27.2%; laparotomy, 32.6%; vaginal, 40.2%; malignant: laparoscopic/robotic, 28.8%; laparotomy, 47.7%; vaginal, 23.5%. Bowel resection was performed in 0.4% of the benign and 2.8% of the malignant cohort. Type of bowel preparation was as follows: benign: none, 93.8%; mechanical bowel preparation only, 4.6%; oral antibiotics only, 1.1%; mechanical bowel preparation with oral antibiotics, 0.5%; malignant: none, 87.2%; mechanical bowel preparation only, 9.6%; oral antibiotics only, 1.8%; mechanical bowel preparation with oral antibiotics, 1.4%. Use of bowel preparation did not decrease rates of surgical site infections, anastomotic leaks, or major morbidity following benign or malignant hysterectomy. Among malignant abdominal hysterectomies, there was no difference in the rates of infectious morbidity between mechanical bowel preparation alone, oral antibiotics alone, or mechanical bowel preparation with oral antibiotics, compared to no preparation. CONCLUSION: Bowel preparation does not protect against surgical site infections or major morbidity following benign or malignant hysterectomy, regardless of surgical approach, and may be safely omitted.
引用
- Kalogera E, Van Houten HK, Sangaralingham LR, et al. Use of bowel preparation does not reduce postoperative infectious morbidity following minimally invasive or open hysterectomies. Am J Obstet Gynecol. 2020. PMID: 32112733. doi:10.1016/j.ajog.2020.02.035
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。